These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2825657)

  • 1. Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.
    Knap AK; Pratt RF
    Biochem J; 1987 Oct; 247(1):29-33. PubMed ID: 2825657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5833-9. PubMed ID: 6098299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of the RTEM-1 thiol beta-lactamase by thiol-selective reagents: evidence for activation of the primary nucleophile of the beta-lactamase active site by adjacent functional groups.
    Knap AK; Pratt RF
    Proteins; 1989; 6(3):316-23. PubMed ID: 2695930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid: kinetics.
    Loosemore MJ; Cohen SA; Pratt RF
    Biochemistry; 1980 Aug; 19(17):3990-5. PubMed ID: 6250581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of inactivation of beta-lactamase I by 6 beta-bromopenicillanic acid.
    Knott-Hunziker V; Orlek BS; Sammes PG; Waley SG
    Biochem J; 1980 Jun; 187(3):797-802. PubMed ID: 6331385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6 beta-Bromopenicillanic acid inactivates beta-lactamase I.
    Knott-Hunziker V; Orlek BS; Sammes PG; Waley SG
    Biochem J; 1979 Jan; 177(1):365-7. PubMed ID: 218563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases.
    Vanwetswinkel S; Fastrez J; Marchand-Brynaert J
    J Antibiot (Tokyo); 1994 Sep; 47(9):1041-51. PubMed ID: 7928692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase inactivation by mechanism-based reagents.
    Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of RTEM beta-lactamase from Escherichia coli by clavulanic acid and 9-deoxyclavulanic acid.
    Charnas RL; Knowles JR
    Biochemistry; 1981 May; 20(11):3214-9. PubMed ID: 7018570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the RTEM-1 cysteine beta-lactamase by iodoacetate. The nature of active-site functional groups and comparisons with the native enzyme.
    Knap AK; Pratt RF
    Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):85-91. PubMed ID: 1989590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ampicillin alone and in combination with different concentrations of 6 beta-bromopenicillanic acid, clavulanic acid and mecillinam.
    Stobberingh EE; Houben AW; van Boven CP
    Scand J Infect Dis; 1987; 19(1):105-12. PubMed ID: 3031812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of beta-lactamase inhibitors with various beta-lactamases.
    Cullmann W
    Chemotherapy; 1990; 36(3):200-8. PubMed ID: 2159863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.
    Pratt RF; Loosemore MJ
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4145-9. PubMed ID: 212736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of beta-lactamase inhibitors in chemotherapy.
    Neu HC
    Pharmacol Ther; 1985; 30(1):1-18. PubMed ID: 3018803
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
    Micetich RG; Maiti SN; Spevak P; Hall TW; Yamabe S; Ishida N; Tanaka M; Yamazaki T; Nakai A; Ogawa K
    J Med Chem; 1987 Aug; 30(8):1469-74. PubMed ID: 3039137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
    Matagne A; Ghuysen MF; Frère JM
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):705-11. PubMed ID: 8240281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.